Humacyte Revenue and Competitors
Estimated Revenue & Valuation
- Humacyte's estimated annual revenue is currently $1.2M per year.
- Humacyte received $150.0M in venture funding in June 2018.
- Humacyte's estimated revenue per employee is $6,836
- Humacyte's total funding is $692.9M.
- Humacyte's current valuation is $600.5M. (January 2022)
Employee Data
- Humacyte has 177 Employees.
- Humacyte grew their employee count by 4% last year.
Humacyte's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | Co-Founder and EVP, Corporate Development | Reveal Email/Phone |
3 | Head Data Management | Reveal Email/Phone |
4 | VP, Operations | Reveal Email/Phone |
5 | SVP, Quality | Reveal Email/Phone |
6 | VP Finance, Corporate Controller | Reveal Email/Phone |
7 | VP, Scientific Affairs | Reveal Email/Phone |
8 | EVP, Business Strategy & People | Reveal Email/Phone |
9 | VP Quality | Reveal Email/Phone |
10 | Executive Director Human Resources | Reveal Email/Phone |
Humacyte Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Humacyte?
Biotechnology Company
keywords:Biotechnology,Healthcare,Pharmaceuticals
$692.9M
Total Funding
177
Number of Employees
$1.2M
Revenue (est)
4%
Employee Growth %
$600.5M
Valuation
N/A
Accelerator
Humacyte News
Humacyte's first product candidate, the human acellular vessels (HAV), is made by seeding human vascular cells from a qualified cell bank...
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues...
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues...
Humacyte, Inc., a Durham, N.C.-based clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, closed a secured debt financing facility with Silicon Valley Bank for up to $50m, of which the first $20m was funded at closing. ...
DURHAM, N.C.--(BUSINESS WIRE)--Humacyte, an innovator in biotechnology and regenerative medicine, received the Medical Technology ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 177 | 11% | N/A |
#2 | $35.4M | 179 | -8% | N/A |
#3 | $36.2M | 180 | 5% | N/A |
#4 | $35M | 181 | -38% | N/A |
#5 | $44.5M | 184 | -2% | N/A |
Humacyte Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-01-22 | $37.3M | Undisclosed | Article | |
| 2015-10-21 | $150.0M | B | Multiple | Article |
| 2016-08-12 | $10.0M | Undisclosed | California Institute for Regenerative Medicine | Article |
| 2017-10-05 | $18.0M | Undisclosed | Article | |
| 2018-03-12 | $75.0M | Undisclosed | PointState Capital | Article |
| 2018-06-12 | $150.0M | Undisclosed | Fresenius Medical Care | Article |